Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Pharma
Gilead's once-rejected hepatitis D med wins FDA nod
More than three years after Gilead's hepatitis D drug was rebuffed by the FDA on manufacturing concerns, the treatment has redeemed itself.
Fraiser Kansteiner
May 26, 2026 9:49am
AZ nets key hypertension nod for Baxfendy, plus new Fasenra use
May 18, 2026 11:23am
Partner's Bizengri passes muster in FDA national priority pilot
May 11, 2026 11:08am
AZ's Breztri picks up 2nd FDA nod, unlocking asthma market
Apr 28, 2026 10:47am
In another win for rare disease, Travere nabs FDA’s first FSGS nod
Apr 13, 2026 6:25pm
Rocket is priming a limited launch of its 1st gene therapy nod
Mar 27, 2026 10:25am
